84
Views
50
CrossRef citations to date
0
Altmetric
Original Article

Famotidine: A Notable Lack of Drug Interactions

Pages 55-60 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vijay V Upreti, Yan Song, Jessie Wang, Wonkyung Byon, Rebecca A Boyd, Janice M Pursley, Frank LaCreta & Charles E Frost. (2013) Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. Clinical Pharmacology: Advances and Applications 5, pages 59-66.
Read now

Articles from other publishers (49)

Shunsuke Nakamura, Shingo Masuda, Shinya Oda, Daisuke Yamakawa, Shota Yamaguchi, Tamaki Ishima, Natsuka Kimura & Kenichi Aizawa. (2024) Polypharmacy-Related Shock Symptoms and Complications Associated with Phenothiazine: A Case Report. Internal Medicine.
Crossref
Moein Mohseni, Vahid Raissi, Yasamin Sharifan, Kimia Barikro, Sasan Amiri, Maedeh Sadat Mohseni, Farid Raeisi, Kimia Masoumi, Sina Khodakarami & Omid Raiesi. (2022) Therapeutic Status of Famotidine in COVID-19 Patients: A Review. Infectious Disorders - Drug Targets 22:3.
Crossref
Siri Kalyan Chirumamilla, Venkatesh Teja Banala, Masoud Jamei & David B. Turner. (2021) Mechanistic PBPK Modelling to Predict the Advantage of the Salt Form of a Drug When Dosed with Acid Reducing Agents. Pharmaceutics 13:8, pages 1169.
Crossref
Yu Jiang, Ziping Liu, Jörg Holenz & Hua Yang. 2016. Lead Generation. Lead Generation 183 220 .
John Chung, Fernando Alvarez-Nunez, Vincent Chow, Dominick Daurio, John Davis, Michael Dodds, Maurice Emery, Kevin Litwiler, Anne Paccaly, Joanna Peng, Brooke Rock, Larry Wienkers, Charles Yang, Zhigang Yu & Jan Wahlstrom. (2015) Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility. Journal of Pharmaceutical Sciences 104:4, pages 1522-1532.
Crossref
Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva & F. Peter Guengerich. (2014) Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes. Drug Metabolism and Disposition 42:9, pages 1438-1446.
Crossref
Toru Arai, Yoshikazu Inoue, Yumiko Sasaki, Kazunobu Tachibana, Keiko Nakao, Chikatoshi Sugimoto, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi & Seiji Hayashi. (2014) Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis. Respiratory Investigation 52:2, pages 136-143.
Crossref
Jodie Pang, Gena Dalziel, Brian Dean, Joseph A. Ware & Laurent Salphati. (2013) Pharmacokinetics and Absorption of the Anticancer Agents Dasatinib and GDC-0941 under Various Gastric Conditions in Dogs – Reversing the Effect of Elevated Gastric pH with Betaine HCl. Molecular Pharmaceutics 10:11, pages 4024-4031.
Crossref
Ophelia Q. P. Yin, Véronique Bédoucha, Tracey McCulloch, Cheng Zheng, Wei Zhou, Azra Hussaini & Steven Novick. (2012) Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers. Cancer Chemotherapy and Pharmacology 71:1, pages 219-226.
Crossref
Alfonso E. Bello. (2012) DUEXIS ® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug . Therapeutic Advances in Musculoskeletal Disease 4:5, pages 327-339.
Crossref
Loren Laine, Alan J Kivitz, Alfonso E Bello, Amy Y Grahn, Michael H Schiff & Ali S Taha. (2012) Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers. American Journal of Gastroenterology 107:3, pages 379-386.
Crossref
Prabowo Tunggal, Fook-Hong Ng, Kwok-Fai Lam, Francis K.L. Chan & Yuk-Kong Lau. (2011) Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: A double-blind, randomized trial. American Heart Journal 162:5, pages 870-874.
Crossref
R. Marcus Fancher, Hongjian Zhang, Bogdan Sleczka, George Derbin, Richard Rockar & Punit Marathe. (2011) Development of a Canine Model to Enable the Preclinical Assessment of Ph-dependent Absorption of Test Compounds. Journal of Pharmaceutical Sciences 100:7, pages 2979-2988.
Crossref
Paraskevas Tzanavaras. (2011) Development and validation of an ultra-fast liquid chromatographic method for the quality control of famotidine formulations using a short monolithic stationary phase. Open Chemistry 9:3, pages 446-452.
Crossref
Matthew Price & Amy Schueler. (2010) Understanding Clopidogrel's Interaction with CYP2C19 Inhibitors. The Journal for Nurse Practitioners 6:9, pages 715-720.
Crossref
Hye-Kyong JeongChang-Hwan ParkChung-Hwan JunGi-Hoon LeeHyung-Il KimHyun-Soo KimSung-Kyu ChoiJong-Sun Rew. (2007) A Prospective Randomized Trial of Either Famotidine or Pantoprazole for the Prevention of Bleeding after Endoscopic Submucosal Dissection. Journal of Korean Medical Science 22:6, pages 1055.
Crossref
Tanja Wegat, Katrin Metzman, Kristina Leuner & Walter E. Müller. (2006) Antazida und H 2 ‐Antihistaminika bei Hyperazidität: Wissenswertes zu Nebenwirkungen und Interaktionen . Pharmazie in unserer Zeit 36:1, pages 44-51.
Crossref
Kamal M. Matar. (2005) Influence of famotidine on verapamil pharmacokinetics in rats. European Journal of Drug Metabolism and Pharmacokinetics 30:3, pages 219-222.
Crossref
T. FURUTA, N. SHIRAI, M. SUGIMOTO, A. NAKAMURA, K. OKUDAIRA, M. KAJIMURA & A. HISHIDA. (2005) Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status. Alimentary Pharmacology and Therapeutics 22:1, pages 67-74.
Crossref
Hideyuki Motohashi, Yuichi Uwai, Kiyo Hiramoto, Masahiro Okuda & Ken-ichi Inui. (2004) Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A). European Journal of Pharmacology 503:1-3, pages 25-30.
Crossref
Wilson Roberto Malfará, Carolina Paula Pereira, Antonio Cardozo Dos Santos & Regina Helena Costa Queiroz. (2002) Effects of H2-receptor antagonists on dapsone-induced methaemoglobinaemia in rats. Pharmacological Research 45:4, pages 269-273.
Crossref
Yoko Iida, Shinichi Nishi & Akira Asada. (2001) Effect of Mild Therapeutic Hypothermia on Phenytoin Pharmacokinetics. Therapeutic Drug Monitoring 23:3, pages 192-197.
Crossref
Humphries & Merritt. (1999) Review article: drug interactions with agents used to treat acid-related diseases. Alimentary Pharmacology & Therapeutics 13, pages 18-26.
Crossref
P Barrau, C Giannelloni, G Gindre, JP Bérard & JE Bazin. (1998) Effet prolongé du midazolam avec retard de réveil postanesthésique par interférence possible avec la famotidine. Annales Françaises d'Anesthésie et de Réanimation 17:5, pages 361-364.
Crossref
Takashi Aono. (1995) The liver regenerative response elicited by antisecretory agents in partially hepatectomized rats: A comparison between omeprazole and famotidine. Surgery Today 25:9, pages 816-821.
Crossref
Bertil KJ Wagner, David W Amory, Claudine M Majcher, Louis T DiFazio, Gregory E Scott & Alan J Spotnitz. (2016) Effects of Intravenous Famotidine on Gastric Acid Secretion in Patients Undergoing Cardiac Surgery. Annals of Pharmacotherapy 29:4, pages 349-353.
Crossref
George D. Prell, Jack Peter Green, Charles A. Kaufmann, Jai K. Khandelwal, Albert M. Morrishow, Darrell G. Kirch, Markku Linnoila & Richard Jed Wyatt. (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophrenia Research 14:2, pages 93-104.
Crossref
Bertil K. J. Wagner, Louis T. Fazio, David W. Amory, Claudine M. Majcher, Alan J. Spotnitz & Gregory E. Scott. (2012) Famotidine Pharmacokinetics in Patients Undergoing Cardiac Surgery. Drug Investigation 8:5, pages 271-277.
Crossref
Kathleen D. Lake, Jacqueline G. Nolen, Ralph A. Slaker, Thomas J. Reutzel, Sherry K. Milfred, Diane F. Solbrack & Frances M. Hoffman. (2016) Over-the-Counter Medications in Cardiac Transplant Recipients: Guidelines for Use. Annals of Pharmacotherapy 26:12, pages 1566-1575.
Crossref
T. Liersch, J. -H. Beyer, G. Krieger & K. Vehmeyer. (1992) The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine. Annals of Hematology 64:5, pages 231-239.
Crossref
Kent D. Katz & Daniel Hollander. (1992) Practical pharmacology and cost-effective management of peptic ulcer disease. The American Journal of Surgery 163:3, pages 349-359.
Crossref
Charles D. Spaulding & Jeffry W. Joseph. (1992) Is Rx Couponing a Viable Direct-Marketing Technique?. American Pharmacy 32:1, pages 67-71.
Crossref
Thomas J. Humphries. (1991) Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole. Digestive Diseases and Sciences 36:12, pages 1665-1669.
Crossref
Kathleen D. Lake. (2012) Management of Drug Interactions With Cyclosporine. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 11:5.
Crossref
Thomas A. Miller, Michael S. Tornwall & Frank G. Moody. (1991) Stress erosive gastritis. Current Problems in Surgery 28:7, pages 459-509.
Crossref
Hisae Doi, Hideo Maruta, Ichidai Kudoh, Yoshiki Takahashi, Osami Takano, Kenichi Ogawa, Keiji Satoh & Yoshito Okutsu. (1991) Placental transfer and effects of famotidine on neonates. Journal of Anesthesia 5:3, pages 276-280.
Crossref
Stephen j. Sontag. (1990) The Medical Management of Reflux Esophagitis. Gastroenterology Clinics of North America 19:3, pages 683-712.
Crossref
Kamlesh P. Vyas, Prasad H. Kari, Regina W. Wang & Anthony Y.H. Lu. (1990) Biotransformation of lovastatin—III. Biochemical Pharmacology 39:1, pages 67-73.
Crossref
Paul F. Souney & Cheryl A. Stoukides. (2016) Pharmacoeconomic Aspects and Formulary Considerations Related to Histamine 2 -Receptor Antagonists . DICP 23:10_suppl, pages S29-S35.
Crossref
Vasilios A. Skoutakis. (2016) Comparison of the Parenteral Histamine 2 -Receptor Antagonists . DICP 23:10_suppl, pages S17-S22.
Crossref
C. GESPACH, D. FAGOT & S. EMAMI. (1989) Pharmacological control of the human gastric histamine H2 receptor by famotidine:comparison with H 1 , H 2 and H 3 receptor agonists and antagonists . European Journal of Clinical Investigation 19:s1, pages 1-10.
Crossref
K. M. COCHRAN, R. COCKEL, J. CROWE, R. J. DICKINSON, A. E. GENT, N. P. KENNEDY, C. M. S. ROYSTON, E. CEDAR & S. G. MANN. (2007) Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer. Alimentary Pharmacology & Therapeutics 3:5, pages 461-470.
Crossref
Dennis F. Thompson, Marsha A. Raebel, Elizabeth K. Hussey & George E. Dukes. (2016) Do All Histamine 2 -Antagonists Cause a Warfarin Drug Interaction? . DICP 23:9, pages 675-679.
Crossref
R. ALCALÁ SANTAELLA, J. GUARDIA, J. PAJARES, J. PIQUÉ, L. PITA, E. ALVÁREZ, P. CASTELLANOS, L. GUARNER, J. ORTIZ, R. PESQUERA, V. VARGAS & R. RUIZ‐CAPELLÁN. (2007) A multicentre, randomized, double‐blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration. Alimentary Pharmacology & Therapeutics 3:1, pages 103-110.
Crossref
M.I. Al-Hassan, S.A. Bawazir, K.M. Matar & A. Tekle. (1989) Effect of famotidine on theophylline pharmacokinetics in the rat. International Journal of Pharmaceutics 50:1, pages 35-38.
Crossref
C. GESPACH, D. FAGOt & S. EMAMI. (2008) Pharmacological control of the human gastric histamine H2 receptor by famotidine: comparison with H 1 , H 2 and H 3 receptor agonists and antagonists . European Journal of Clinical Investigation 19:1, pages 1-10.
Crossref
N. Inotsume, M. Nishimura, S. Fujiyama, K. Sagara, T. Sato, Y. Imai, H. Matsui & M. Nakano. (1989) Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers. European Journal of Clinical Pharmacology 36:5, pages 517-520.
Crossref
R. Giacomelli, V. Filingeri, G. Famularo, A. Calogero, F. Stortoni, S. Nardi, R. Rosati, A. Iacona, S. Sacchetti, V. Cervelli, R. Verna, G. Tonietti & C. U. Casciani. 1989. Current Therapy in Nephrology. Current Therapy in Nephrology 529 531 .
Jean-Pierre Aymard, Bernadette Aymard, Patrick Netter, Bernard Bannwarth, Philippe Trechot & François Streiff. (2012) Haematological Adverse Effects of Histamine H2-Receptor Antagonists. Medical Toxicology 3:6, pages 430-448.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.